(Q77485532)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9794830%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

review article

1 reference

title

Tumor expression of Fas ligand (CD95L) and the consequences (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9794830%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9794830%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Philippe Saas

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9794830%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

author name string

P Y Dietrich

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9794830%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

publication date

1 October 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9794830%20AND%20SRC:MED&resulttype=core&format=json

Current Opinion in Immunology

6 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9794830%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9794830%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9794830%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

564-572

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9794830%20AND%20SRC:MED&resulttype=core&format=json

Apoptosis by death factor

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Homeostasis and self-tolerance in the immune system: turning lymphocytes off.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Pathways leading to cell death in T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

A role for CD95 ligand in preventing graft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Gene transfer of Fas ligand induces tumor regression in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Expression of Fas ligand in liver metastases of human colonic adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Antitumor effect of locally produced CD95 ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Transplantation of CD95 ligand-expressing grafts: influence of transplantation site and difficulty in protecting allo- and xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Inhibition of the alloantibody response by CD95 ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

The role of Fas in autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

T cell receptor signals enhance susceptibility to Fas-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

CD4 regulates susceptibility to Fas ligand- and tumor necrosis factor-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Requirement of cell-cell contact in the induction of Jurkat T cell apoptosis: the membrane-anchored but not soluble form of FasL can trigger anti-CD3-induced apoptosis in Jurkat T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Downregulation of Fas ligand by shedding

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Polymorphism of murine Fas ligand that affects the biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Human Fas ligand: gene structure, chromosomal location and species specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Metalloproteinase-mediated release of human Fas ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Fas ligand in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Fas and FasL in the homeostatic regulation of immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Fas signal transduction triggers either proliferation or apoptosis in human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Activation and activation-induced death of human tonsillar B cells and Burkitt lymphoma cells: lack of CD95 (Fas/APO-1) ligand expression and function

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Malignant and reactive cells from human lymphomas frequently express Fas ligand but display a different sensitivity to Fas-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Nasal T/NK cell lymphomas commonly express perforin and Fas ligand: important mediators of tissue damage

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Constitutive expression of Fas ligand in large granular lymphocyte leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L).

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1/Fas)-CD95 ligand-induced suicide

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Epression of the Apoptosis-Inducing FAS Ligand (FASL) in Human First and Third Trimester Placenta and Choriocarcinoma Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Role of reactive oxygen intermediates in activation-induced CD95 (APO-1/Fas) ligand expression

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

Role of the Fas/Fas ligand pathway in apoptotic cell death induced by the human T cell lymphotropic virus type I Tax transactivator

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

ICE-proteases mediate HTLV-I Tax-induced apoptotic T-cell death.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980225-2

7 January 2021

10.1016/S0952-7915(98)80225-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9794830%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference